Alectinib Pharmacokinetic in Patients With NSCLC

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Non-small Cell Lung Cancer Stage IIIB · ALK Gene Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional de Cancerología, Mexico City, Mexico City, Mexico
Contact: Study coordinator (Oscar G Arrieta, M.D., M.Sc.) · ogar@unam.mx · 5556280400

Study leads

Oscar G Arrieta Rodriguez, M.D., M.Sc.
Principal Investigator
Instituto Nacional de Cancerologia de Mexico

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Los Angeles, United States

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer · Non-small Cell Lung Cancer Stage II · Non-Small Cell Lung Cancer Stage IIIA

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States · Rochester, United States

AK129 Combination Therapy for Advanced Solid Tumors

Non-small Cell Lung Cancer Stage IIIB/IV · Head and Neck Squamous Cell Carcinoma (HNSCC) · Colorectal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenyang, China

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Non-Small Cell Lung Cancer · RET Driver Mutation · BRAF V600 Mutation

Abroad (travel likely)RecruitingPHASE2

Guanzhou, China